MSB 8.43% $1.35 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-36

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 500 Posts.
    lightbulb Created with Sketch. 251
    It was always going to be accepted.
    6 month PDUFA is piss poor.
    Watch the shorts increase and the manipulation continue.
    At least SI has changed his dialogue to “potential” approval.

    Share price has gone up 14%. Watch it come back down over the next few days/weeks. And before people start banging on about the Nasdaq about to go bananas…it probably won’t.

    IMO this is the not the best outcome. FDA must have a bit more to pick apart by needing 6 months.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.